Inactive Instrument

Biotech Acquisition Company Stock

BIOT

KYG1125A1085

Chart Biotech Acquisition Company

Duration

Period

Style

Dynamic Chart

Latest news about Biotech Acquisition Company

Biotech Acquisition to Dissolve, Liquidate	23-02-02	MT
Biotech Acquisition Company(NasdaqCM:BIOT) dropped from NASDAQ Composite Index	23-02-02	CI
Biotech Acquisition Says New Sponsor to Make Additional Contributions Related to Proposed Business Combination Extension	23-01-05	MT
Biotech Acquisition Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-22	CI
Biotech Acquisition Company announced that it expects to receive $0.25 million in funding	22-10-03	CI
Biotech Acquisition, Blade Therapeutics Agree to Terminate Merger Agreement	22-06-13	MT
Biotech Acquisition Company cancelled the transaction announced on November 8, 2021	22-06-09	CI
Blade Therapeutics, Inc. cancelled the acquisition of Biotech Acquisition Company from Biotech Sponsor LLC and others in a reverse merger transaction.	22-06-09	CI
Biotech Acquisition Postpones Extraordinary Meeting of Shareholders to Approve Proposed Merger With Blade Therapeutics	22-06-03	MT
Biotech Acquisition Company Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Blade Therapeutics Gets FDA Feedback Letter for Cudetaxestat	22-04-04	DJ
Biotech Acquisition Company Auditor Raises 'Going Concern' Doubt	22-03-07	CI
Blade Therapeutics Says Treatment for Lung Scarring Condition Was Well Tolerated in Phase 1 Study	22-01-12	MT
Blank Check Firm Biotech Acquisition to Merge With Blade Therapeutics	21-11-08	MT
Biotech Acquisition Company announced that it expects to receive $24.3 million in funding from Bristol-Myers Squibb Company, Deerfield Management Company, L.P., Pfizer Venture Investments LLC, Osage University Partners, MPM Asset Management, L.L.C. and other investors	21-11-07	CI

More news

Press releases Biotech Acquisition Company

BIOTECH ACQUISITION CO : Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	23-02-02	AQ
Biotech Acquisition Company Announces Liquidation	23-02-01	GL
Biotech Acquisition Company Announces Liquidation	23-02-01	AQ
BIOTECH ACQUISITION CO : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	23-01-25	AQ
BIOTECH ACQUISITION CO : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	23-01-11	AQ

More press releases

News in other languages on Biotech Acquisition Company

Bolsa de Madrid: Dura Lex, Fed Lex	22-04-06
OPINIONES DE LOS ANALISTAS DEL DÍA : Santander, Stellantis, BT, Givaudan, Biotech, BASF, TechnipFMC, Abrdn, Adyen...	21-12-08
OPINIONES DE LOS ANALISTAS DEL DÍA : AXA, Bayer, Merck, Nordex, Subsea, Geberit, Biontech, Glaxosmithkline, Siemens Healthineers...	21-11-22
Coronavirus vs. Black Friday	21-11-22

More news

Managers and Directors - Biotech Acquisition Company

Managers	Title	Age	Since
Michael Shleifer CEO	Chief Executive Officer	49	-
Thomas Fratacci DFI	Director of Finance/CFO	46	20-08-31
Ivan Jarry COO	Chief Operating Officer	45	20-08-31

Members of the board	Title	Age	Since
Albert F. Hummel CIO	Chief Investment Officer	78	20-08-31
Bruno Montanari BRD	Director/Board Member	49	21-01-24
Paul D. Bernard BRD	Director/Board Member	55	21-01-24

More insiders

Biotech Acquisition Company is a blank check company. The Company is created for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses. The Company focuses for a target business in the healthcare sector. It has no operations and has no revenues.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+137.37%	5.68B
SCREAMING EAGLE ACQUISITION CORP.	+1.89%	1.01B
CHURCHILL CAPITAL CORP VII	+2.19%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+25.27%	819M
ARES ACQUISITION CORPORATION II	+1.68%	663M
E7 GROUP	+0.54%	610M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ALTC ACQUISITION CORP.	+21.31%	552M